Finally, a recent work on pediatric patients with BCP-ALL showed that the specific aberrant splicing variants of the CD22 gene were associated with antigen downregulation and an acquired resistance to InO [70]. The gene discussed is CD22; the disease is acute lymphoblastic leukemia.